Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Nike
NKE
|
+$631M |
| 2 |
PNC Financial Services
PNC
|
+$614M |
| 3 |
XYZ
Block, Inc.
XYZ
|
+$328M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$275M |
| 5 |
FedEx
FDX
|
+$236M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.16B |
| 2 |
Meta Platforms (Facebook)
META
|
+$595M |
| 3 |
AbbVie
ABBV
|
+$489M |
| 4 |
Crown Castle
CCI
|
+$326M |
| 5 |
McDonald's
MCD
|
+$325M |
Sector Composition
| 1 | Technology | 20.85% |
| 2 | Consumer Discretionary | 16.57% |
| 3 | Financials | 13.84% |
| 4 | Healthcare | 12.56% |
| 5 | Communication Services | 11.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Penumbra
PEN
$10.6B
| $330K | ﹤0.01% |
2,854
-1,234
| -30% | -$143K |
|
627
Coherus Oncology, Inc. Common Stock
CHRS
$152M
| $311K | ﹤0.01% |
+28,142
| New | +$311K |
|
628
German American Bancorp
GABC
$1.53B
| $309K | ﹤0.01% |
9,279
-57
| -0.6% | -$1.9K |
|
|
CORE
629
DELISTED
Core Mark Holding Co., Inc.
CORE
| $309K | ﹤0.01% |
14,554
-40,435
| -74% | -$858K |
|
|
HDP
630
DELISTED
Hortonworks, Inc.
HDP
| $309K | ﹤0.01% |
+15,163
| New | +$309K |
|
631
NeoGenomics
NEO
$966M
| $301K | ﹤0.01% |
+36,848
| New | +$301K |
|
|
FNSR
632
DELISTED
Finisar Corp
FNSR
| $299K | ﹤0.01% |
18,893
+5,136
| +37% | +$81.3K |
|
633
Intuit
INTU
$183B
| $289K | ﹤0.01% |
1,668
-181,536
| -99% | -$31.5M |
|
634
RLI Corp
RLI
$6.08B
| $286K | ﹤0.01% |
9,026
-1,264
| -12% | -$40.1K |
|
|
COUP
635
DELISTED
Coupa Software Incorporated
COUP
| $279K | ﹤0.01% |
+6,120
| New | +$279K |
|
636
Woodward
WWD
$14.4B
| $278K | ﹤0.01% |
3,874
-1,199
| -24% | -$86K |
|
637
Service Corp International
SCI
$11.3B
| $277K | ﹤0.01% |
7,352
+1,353
| +23% | +$51K |
|
638
Viavi Solutions
VIAV
$2.66B
| $275K | ﹤0.01% |
28,340
-153,402
| -84% | -$1.49M |
|
|
CSII
639
DELISTED
Cardiovascular Systems, Inc.
CSII
| $252K | ﹤0.01% |
11,495
-3,966
| -26% | -$86.9K |
|
|
HES
640
DELISTED
Hess
HES
| $246K | ﹤0.01% |
4,854
-13,618
| -74% | -$690K |
|
641
NOV
NOV
$4.94B
| $236K | ﹤0.01% |
6,398
-13,702
| -68% | -$505K |
|
642
Standard BioTools
LAB
$489M
| $235K | ﹤0.01% |
+40,271
| New | +$235K |
|
643
ArcelorMittal
MT
$26.7B
| $222K | ﹤0.01% |
6,966
-19,545
| -74% | -$623K |
|
644
Nucor
NUE
$32.6B
| $212K | ﹤0.01% |
3,463
-9,715
| -74% | -$595K |
|
645
PPG Industries
PPG
$24.6B
| $212K | ﹤0.01% |
1,899
-5,327
| -74% | -$595K |
|
646
Phillips 66
PSX
$53.1B
| $212K | ﹤0.01% |
2,205
-4,519
| -67% | -$434K |
|
|
B
647
Barrick Mining Corporation
B
$50.2B
| $191K | ﹤0.01% |
15,368
-43,170
| -74% | -$537K |
|
|
MRO
648
DELISTED
Marathon Oil Corporation
MRO
| $176K | ﹤0.01% |
10,929
-30,717
| -74% | -$495K |
|
649
Adverum Biotechnologies
ADVM
$69.5M
| – | – |
-30,208
| Closed | -$1.06M |
|
650
Allegion
ALLE
$14.6B
| – | – |
-714,561
| Closed | -$56.9M |
|